Since SHANK3 is highly enriched in synapses, we also assessed the level of SHANK3 in synaptosome extracts from parietotemporal cortex and detected lower levels of SHANK3a (−53%) in individuals with a diagnosis of AD (Fig. 1B). This evidence concerns the gene SHANK3 and Alzheimer disease.